Welcome visitor Log In - or - Register
(
0 items /
$0.00
)
View Cart
Check Out
four ways
Quick Search:
KRLS-017
KRLS-017 is an orally bioavailable, potent and highly selective reversible CDK7 inhibitor. Displays antitumor efficacy in multiple xenograft models (ref. 1). Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis (ref. 2).
Catalog NO: CT-KRLS017
Synonym: KRLS017
CAS NO: 2055741-42-7
Mol. Formula: C24H35N5O2Si
MW: 453.7 (or refer to the Certificate of Analysis, batch-specific)
** in vivo Quality Material. >99% Pure by HPLC (attached). Bulk stock (Discounted price for 0.2G, 0.5G, 1G, …,). Same Day Shipping.